Las Vegas, NV -- (SBWIRE) -- 09/21/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Boston Scientific Corporation (NYSE:BSX), Agilent Technologies Inc.(NYSE:A), Bristol-Myers Squibb Co(NYSE:BMY), Express Scripts Holding Company(NASDAQ:ESRX)
Boston Scientific Corporation (NYSE:BSX) managed to keep its fall at -0.94% on below-normal volume of 11.12 million shares. The stock settled at $11.63 after floating in a range of $11.62 to $11.85. Its latest price was $11.63, reaching market capitalization of $15.62 billion. Its 52-week range has been $5.04 to $12.16. Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide.
Has BSX Found The Bottom and Ready To Move Up? Find Out Here
Agilent Technologies Inc.(NYSE:A) traded up on a volume of 10.69 million, higher than its standard daily volume. Shares have gained 2.30% to $11.53. Over the last twelve months, the stock has added 32.26% and faced a worst price of $50.98. Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide.
For How Long A will Fight for Profitability? Read This Trend Analysis report
Bristol-Myers Squibb Co(NYSE:BMY) settled -1.58% lower at $46.78 on above-normal volume of 9.97 million shares during the last trading day. The stock has its 12-month high at $49.57 and 52-week low price was $30.64. It traded in a range of $46.67 to $47.59 during the last trading day. Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. Its principal products include Plavix for protection against fatal or non-fatal heart attack or stroke.
Why Should Investors Buy BMY After the Recent Fall ? Just Go Here and Find Out
Express Scripts Holding Company(NASDAQ:ESRX) saw its price gain on above-normal volume, as 10.10 million shares changed hands when compared with its average daily volume of 4.10 million shares. The stock was up 0.18% to $62.05. It has fallen over the last 12 months, dropping -1.26% and marked new low $61.89. Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada
Why Should Investors Buy ESRX After The Recent Gain? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)